Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthase

Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance

Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,788 · see citing works

Antifungal agents: mechanisms of action

Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202 · see citing works

Discovery of Novel Antifungal (1,3)-β- d -Glucan Synthase Inhibitors

Onishi, J. C., Meinz, M., Thompson, J. R., Curotto, J. E., Dreikorn, S., Rosenbach, M. J., Douglas, C. M., Abruzzo, G. K., Flattery, A. M., Kong, L., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.368-377.2000 · Cited by 326 · see citing works

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

Abruzzo, G. K., Flattery, A. M., Gill, C. J., Kong, L., Smith, J. G., Pikounis, V. B., Balkovec, J. M., Bouffard, A., Dropinski, J. F., Rosen, H., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2333 · Cited by 241 · see citing works

Microbial natural products as a source of antifungals

Vicente, M. F., Basilio, Á., Cabello, A., & Peláez, F. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00489.x · Cited by 191 · see citing works

New Targets and Screening Approaches in Antimicrobial Drug Discovery

Brown, E. D., & Wright, G. D. (2005) · Chemical Reviews · doi:10.1021/cr030116o · Cited by 185 · see citing works

Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives

Bouffard, F. A., Zambias, R. A., Dropinski, J. F., Balkovec, J. M., Hammond, M. L., Abruzzo, G. K., Bartizal, K. F., Marrinan, J. A., & Kurtz, M. B. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00028a003 · Cited by 113 · see citing works

Powdered KOH in DMSO: An Efficient Base for Asymmetric Cyclization via Memory of Chirality at Ambient Temperature

Kawabata, T., Moriyama, K., Kawakami, S., & Tsubaki, K. (2008) · Journal of the American Chemical Society · doi:10.1021/ja077684w · Cited by 85 · see citing works

Asymmetric Cyclization via Memory of Chirality: A Concise Access to Cyclic Amino Acids with a Quaternary Stereocenter

Kawabata, T., Kawakami, S., & Majumdar, S. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0378299 · Cited by 84 · see citing works

Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP)

Balkovec, J. M., Black, R. M., Hammond, M. L., Heck, J. V., Zambias, R. A., Abruzzo, G. K., Bartizal, K. F., Kropp, H., & Trainor, C. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00079a027 · Cited by 72 · see citing works

Isolation and Structural Determination of Enfumafungin, a Triterpene Glycoside Antifungal Agent That Is a Specific Inhibitor of Glucan Synthesis

Schwartz, R. E., Smith, S. K., Onishi, J. C., Meinz, M. S., Kurtz, M. B., GIACOBBE, R. A., Wilson, K. E., Liesch, J. M., Zink, D. L., Horn, W. S., et al. (2000) · Journal of the American Chemical Society · doi:10.1021/ja9944296 · Cited by 61 · see citing works

Synthesis of the Antifungal β-1,3-Glucan Synthase Inhibitor CANCIDAS (Caspofungin Acetate) from Pneumocandin B0

William R. Leonard, Belyk, K. M., Conlon, D. A., Bender, D. R., DiMichele, L. M., Liu, J., & Hughes, D. L. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo062008i · Cited by 46 · see citing works

METABOLIC ACTIVATION OF FLUOROPYRROLIDINE DIPEPTIDYL PEPTIDASE-IV INHIBITORS BY RAT LIVER MICROSOMES

Xu, S. S., Zhu, B., Teffera, Y., Pan, D., Caldwell, C. G., Doss, G. A., Stearns, R. A., Evans, D. C., & Beconi, M. G. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001842 · Cited by 36 · see citing works

Isoxazole Functionalization Technologies Enable Construction of Tetracycline Derivatives

Heasley, B. H. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201102480 · Cited by 35 · see citing works

Alternate Routes in the Metabolic Degradation of the Pyrrolidine Ring of Nicotine

McKennis, H., Schwartz, S. L., & Bowman, E. R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91232-9 · Cited by 29 · see citing works

Natural product and natural product derived drugs in clinical trials

Butler, M. S., Robertson, A. A. B., & Cooper, M. A. (2014) · Natural Product Reports · doi:10.1039/c4np00064a · Cited by 605 · see citing works

Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches

Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593 · see citing works

<i>Candida</i>Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents

Spampinato, C., & Leonardi, D. (2013) · BioMed Research International · doi:10.1155/2013/204237 · Cited by 411 · see citing works

The fungal cell wall as a target for the development of new antifungal therapies

Cortés, J. C. G., Curto, M.-Á., Carvalho, V. S. D., Pérez, P., & Ribas, J. C. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.008 · Cited by 172 · see citing works

Antifungal drugs: New insights in research & development

Nicola, A. M., Albuquerque, P., Paes, H. C., Fernandes, L., Costa, F. F., Kioshima, É. S., Abadio, A. K. R., Bocca, A. L., & Felipe, M. S. S. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.008 · Cited by 143 · see citing works

Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis

Wring, S. A., Randolph, R., Park, S., Abruzzo, G. K., Chen, Q., Flattery, A. M., Garrett, G. C., Peel, M. R., Outcalt, R. J., Powell, K. D., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02068-16 · Cited by 94 · see citing works

Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections

Ghannoum, M. A., Arendrup, M. C., Chaturvedi, V. P., Lockhart, S. R., McCormick, T. S., Chaturvedi, S., Berkow, E. L., Juneja, D., Tarai, B., Azie, N. E., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9090539 · Cited by 92 · see citing works

SCY-078 is fungicidal against Candida species in time-kill studies

Scorneaux, B., Angulo, D., Borroto-Esoda, K., Ghannoum, M., Peel, M., & Wring, S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01961-16 · Cited by 88 · see citing works

Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall

Liu, W., Yuan, L., & Wang, S. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00748 · Cited by 80 · see citing works

Novel antifungal agents: a patent review (2011 – present)

Castelli, M. V., Butassi, E., Monteiro, M. C., Svetaz, L. A., Vicente, F., & Zacchino, S. A. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.876993 · Cited by 72 · see citing works

Ten decadal advances in fungal biology leading towards human well-being

Mapook, A., Hyde, K. D., Hassan, K., Kemkuignou, B. M., Čmoková, A., Surup, F., Kuhnert, E., Paomephan, P., Cheng, T., de Hoog, S., et al. (2022) · Fungal Diversity · doi:10.1007/s13225-022-00510-3 · Cited by 72 · see citing works

Drugs in Clinical Development for Fungal Infections

González-Lara, M. F., Sifuentes‐Osornio, J., & Ostrosky‐Zeichner, L. (2017) · Drugs · doi:10.1007/s40265-017-0805-2 · Cited by 65 · see citing works

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

Gamal, A., Chu, S., McCormick, T. S., Borroto-Esoda, K., Angulo, D., & Ghannoum, M. A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.642358 · Cited by 58 · see citing works

In pursuit of the ideal antifungal agent for Candida infections: high-throughput screening of small molecules

Wong, S. S. W., Samaranayake, L. P., & Seneviratne, C. J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.009 · Cited by 56 · see citing works

The Role of Natural Product Chemistry in Drug Discovery: Two Decades of Progress and Perspectives

Butler, M. S., & Clair, J. J. L. (2025) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5c01368 · Cited by 53 · see citing works

Maleimide structure: a promising scaffold for the development of antimicrobial agents

Ma, Z., Qiu, S., Chen, H., Zhang, D., Lu, Y., & Chen, X. (2021) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2021.1877675 · Cited by 47 · see citing works

Formyl peptide receptor modulators: a patent review and potential applications for inflammatory diseases (2012-2015)

Tsai, Y., Yang, S., & Hwang, T. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1216546 · Cited by 45 · see citing works

Enfumafungin synthase represents a novel lineage of fungal triterpene cyclases

Kuhnert, E., Li, Y., Lan, N., Yue, Q., Chen, L., Cox, R. J., An, Z., Yokoyama, K., & Bills, G. F. (2018) · Environmental Microbiology · doi:10.1111/1462-2920.14333 · Cited by 42 · see citing works

Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin

Apgar, J. M., Wilkening, R. R., Greenlee, M. L., Balkovec, J. M., Flattery, A. M., Abruzzo, G. K., Galgoci, A. M., GIACOBBE, R. A., Gill, C., Hsu, M. J., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.011 · Cited by 34 · see citing works

Fungal Bioactive Compounds in Pharmaceutical Research and Development

Saxena, S., Chhibber, M., & Singh, I. P. (2018) · Current Bioactive Compounds · doi:10.2174/1573407214666180622104720 · Cited by 30 · see citing works

Solanocapsine derivatives as potential inhibitors of acetylcholinesterase: Synthesis, molecular docking and biological studies

García, M. E., Borioni, J. L., Cavallaro, V., Puiatti, M., Pierini, A. B., Murray, A. P., & Peñéñory, A. B. (2015) · Steroids · doi:10.1016/j.steroids.2015.09.001 · Cited by 27 · see citing works

Biosynthesis of Enfumafungin-type Antibiotic Reveals an Unusual Enzymatic Fusion Pattern and Unprecedented C–C Bond Cleavage

Cao, Z., Wang, G., Luo, R., Gao, Y., Lv, J., Qin, S.-Y., Chen, G., Awakawa, T., Bao, X.-F., Mei, Q., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c02415 · Cited by 22 · see citing works

Recent advances in the treatment of life-threatening, invasive fungal infections

Drew, R. H., Townsend, M. L., Pound, M. W., Johnson, S. W., & Perfect, J. R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.838217 · Cited by 22 · see citing works

Preparation, Antidermatophyte Activity, and Mechanism of Methylphloroglucinol Derivatives

Ye, L., Lin, P., Du, W., Wang, Y. Y., Tang, C., & Shen, Z. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02262 · Cited by 15 · see citing works

Fungerps: discovery of the glucan synthase inhibitor enfumafungin and development of a new class of antifungal triterpene glycosides

Vicente, F., Reyes, F., & Genilloud, O. (2024) · Natural Product Reports · doi:10.1039/d4np00044g · Cited by 14 · see citing works

Antifungal activity of a maleimide derivative: disruption of cell membranes and interference with iron ion homoeostasis

Chen, C., Xie, Z., Liu, C., Mao, S., Wang, L., Wu, Y., Zhang, Y. L., Zhou, Q., Ahmad, A., Chang, W., et al. (2024) · Mycology&#58 An International Journal on Fungal Biology · doi:10.1080/21501203.2024.2330403 · Cited by 12 · see citing works

Natural Enfumafungin Analogues from Hormonema carpetanum and Their Antifungal Activities

Cheng, Z., Wu, W., Liu, Y., Chen, S., Li, H., Yang, X., Zhu, X., Chen, X., Yan, L., Chu, Z.-Y., et al. (2023) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c00562 · Cited by 12 · see citing works

Existing and emerging therapies for the treatment of invasive candidiasis and candidemia

Bels, D. D., Maillart, E., Françoise Van Bambeke, A., Redant, S., & Honoré, P. M. (2022) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2022.2142207 · Cited by 11 · see citing works

Antifungal Chemistry Review

Birch, M., & Sibley, G. E. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12410-2 · Cited by 10 · see citing works

Draft genome sequence and annotation of the enfumafungin producing fungus Hormonema carpetanum ATCC 74360

Chen, H., Wang, J., Yang, S., Tang, J., Tang, W., & Chen, S. (2025) · BMC Genomic Data · doi:10.1186/s12863-025-01348-9 · Cited by 2 · see citing works

Synthetic studies on enfumafungin: stereoselective synthesis of the CD ring segment

Fujitani, M., & Tanino, K. (2016) · Tetrahedron Letters · doi:10.1016/j.tetlet.2016.09.057 · Cited by 2 · see citing works

Yeast: a microbe with macro-implications to antimicrobial drug discovery

Balibar, C. J., & Roemer, T. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv038 · Cited by 2 · see citing works

Natural Product-Inspired Antifungal Drugs Introduced for Human Use from 1872 to August 2026

Butler, M. S., & Capon, R. J. (2026) · Antibiotics · doi:10.3390/antibiotics15090938 · Cited by 1 · see citing works

In Silico Analysis of Active Compounds of Peruvian Medicinal Plants with Antifungal Activity

Torre, V. E. V.-L., López-Gamboa, J. A., Espinoza-Chávez, R. M., & Chávez‐Fumagalli, M. Á. (2026) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-026-00737-0

Improvement of enfumafungin production by Hormonema carpetanum via mutagenesis and process optimization: mutant generation and preliminary transcriptomic analysis

Chen, H., Wang, J., Huang, H., Gui, J., Yang, S., Tang, W., Tang, J., & Chen, S. (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-026-04847-8

BindingDB Entry 50012651: Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.

BindingDB (2022) · UC San Diego · doi:10.7270/q2348q30

BindingDB Entry 50006411: Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin.

BindingDB (2020) · UC San Diego · doi:10.7270/q2df6v64

Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin

Apgar, J. M., Wilkening, R. R., Greenlee, M. L., Balkovec, J. M., Flattery, A. M., Abruzzo, G. K., Galgoci, A. M., GIACOBBE, R. A., Gill, C., Hsu, M. J., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.011 · Cited by 34 · see citing works

Synthesis of Antifungal Glucan Synthase Inhibitors from Enfumafungin

Zhong, Y., Gauthier, D. R., Shi, Y., McLaughlin, M., Chung, J. Y. L., Dagneau, P., Marcune, B. F., Krska, S. W., Ball, R. G., Reamer, R. A., et al. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo300046v · Cited by 22 · see citing works

Discovery of Novel Antifungal (1,3)-β- d -Glucan Synthase Inhibitors

Onishi, J. C., Meinz, M., Thompson, J. R., Curotto, J. E., Dreikorn, S., Rosenbach, M. J., Douglas, C. M., Abruzzo, G. K., Flattery, A. M., Kong, L., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.368-377.2000 · Cited by 326 · see citing works

MK-5204: An orally active β-1,3-glucan synthesis inhibitor

Apgar, J. M., Wilkening, R. R., Parker, D. L., Meng, D., Wildonger, K. J., Sperbeck, D. M., Greenlee, M. L., Balkovec, J. M., Flattery, A. M., Abruzzo, G. K., et al. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127357 · Cited by 7 · see citing works

New β-glucan inhibitors as antifungal drugs

Hector, R. F., & Bierer, D. E. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.603899 · Cited by 34 · see citing works